Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

20051,638 citationsJournal Articlebronze Open Access

Authors

Nebivolol, a beta-blocker with vasodilating properties, is an effective and well-tolerated treatment for heart failure in the elderly.

Good health and well-being

Published in: European Heart Journal

Volume 26, Issue 3, pp. 215-225

Field-Weighted Citation Impact: 60.59